PROVIDER – Biosimilars: Good News, But Not The New Generics
6/
04
PROVIDER – Biosimilars: Good News, But Not The New Generics
The U.S. Food and Drug Administration (FDA) approved the first biosimilar in early March. Three others are undergoing the agency’s review, which is just the tip of the iceberg, as more biologics reach their patent cliff and manufacturers look to develop alternatives in the form of these effective and less expensive medications.